18 research outputs found
SLC25A51 is a mammalian mitochondrial NAD+ transporter
Mitochondria require nicotinamide adenine dinucleotide (NAD+) to carry out the fundamental processes that fuel respiration and mediate cellular energy transduction. Mitochondrial NAD+ transporters have been identified in yeast and plants1,2, but their existence in mammals remains controversial3,4,5. Here we demonstrate that mammalian mitochondria can take up intact NAD+, and identify SLC25A51 (also known as MCART1)âan essential6,7 mitochondrial protein of previously unknown functionâas a mammalian mitochondrial NAD+ transporter. Loss of SLC25A51 decreases mitochondrialâbut not whole-cellâNAD+ content, impairs mitochondrial respiration, and blocks the uptake of NAD+ into isolated mitochondria. Conversely, overexpression of SLC25A51 or SLC25A52 (a nearly identical paralogue of SLC25A51) increases mitochondrial NAD+ levels and restores NAD+ uptake into yeast mitochondria lacking endogenous NAD+ transporters. Together, these findings identify SLC25A51 as a mammalian transporter capable of importing NAD+ into mitochondria.acceptedVersio
Cell size is a determinant of stem cell potential during aging
Stem cells are remarkably small. Whether small size is important for stem cell function is unknown. We find that hematopoietic stem cells (HSCs) enlarge under conditions known to decrease stem cell function. This decreased fitness of large HSCs is due to reduced proliferation and was accompanied by altered metabolism. Preventing HSC enlargement or reducing large HSCs in size averts the loss of stem cell potential under conditions causing stem cell exhaustion. Last, we show that murine and human HSCs enlarge during aging. Preventing this age-dependent enlargement improves HSC function. We conclude that small cell size is important for stem cell function in vivo and propose that stem cell enlargement contributes to their functional decline during aging.Peer reviewe
Improved Annotation of Untargeted Metabolomics Data through Buffer Modifications That Shift Adduct Mass and Intensity
Combining Metabolomics and Experimental Evolution Reveals Key Mechanisms Underlying Longevity Differences in Laboratory Evolved Drosophila melanogaster Populations
Experimental evolution with Drosophila melanogaster has been used extensively for decades to study aging and longevity. In recent years, the addition of DNA and RNA sequencing to this framework has allowed researchers to leverage the statistical power inherent to experimental evolution to study the genetic basis of longevity itself. Here, we incorporated metabolomic data into to this framework to generate even deeper insights into the physiological and genetic mechanisms underlying longevity differences in three groups of experimentally evolved D. melanogaster populations with different aging and longevity patterns. Our metabolomic analysis found that aging alters mitochondrial metabolism through increased consumption of NAD+ and increased usage of the TCA cycle. Combining our genomic and metabolomic data produced a list of biologically relevant candidate genes. Among these candidates, we found significant enrichment for genes and pathways associated with neurological development and function, and carbohydrate metabolism. While we do not explicitly find enrichment for aging canonical genes, neurological dysregulation and carbohydrate metabolism are both known to be associated with accelerated aging and reduced longevity. Taken together, our results provide plausible genetic mechanisms for what might be driving longevity differences in this experimental system. More broadly, our findings demonstrate the value of combining multiple types of omic data with experimental evolution when attempting to dissect mechanisms underlying complex and highly polygenic traits such as aging
Comparative metabolomic profiling reveals that dysregulated glycolysis stemming from lack of salvage NADâș biosynthesis impairs reproductive development in Caenorhabditis elegans
Temporal developmental progression is highly coordinated in Caenorhabditis elegans. However, loss of nicotinamidase PNC-1 activity slows reproductive development, uncoupling it from its typical progression relative to the soma. Using LC/MS we demonstrate that pnc-1 mutants do not salvage the nicotinamide released by NAD(+) consumers to resynthesize NAD(+), resulting in a reduction in global NAD(+) bioavailability. We manipulate NAD(+) levels to demonstrate that a minor deficit in NAD(+) availability is incompatible with a normal pace of gonad development. The NAD(+) deficit compromises NAD(+) consumer activity, but we surprisingly found no functional link between consumer activity and reproductive development. As a result we turned to a comparative metabolomics approach to identify the cause of the developmental phenotype. We reveal widespread metabolic perturbations, and using complementary pharmacological and genetic approaches, we demonstrate that a glycolytic block accounts for the slow pace of reproductive development. Interestingly, mitochondria are protected from both the deficiency in NAD(+) biosynthesis and the effects of reduced glycolytic output. We suggest that compensatory metabolic processes that maintain mitochondrial activity in the absence of efficient glycolysis are incompatible with the requirements for reproductive development, which requires high levels of cell division. In addition to demonstrating metabolic requirements for reproductive development, this work also has implications for understanding the mechanisms behind therapeutic interventions that target NAD(+) salvage biosynthesis for the purposes of inhibiting tumor growth
NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis
Metabolic reprogramming and metabolic plasticity allow cancer cells to fine-tune their metabolism and adapt to the ever-changing environments of the metastatic cascade, for which lipid metabolism and oxidative stress are of particular importance. NADPH is a central co-factor for both lipid and redox homeostasis, suggesting that cancer cells may require larger pools of NADPH to efficiently metastasize. NADPH is recycled through reduction of NADP+ by several enzymatic systems in cells; however, de novo NADP+ is synthesized only through one known enzymatic reaction, catalyzed by NAD+ kinase (NADK). Here, we show that NADK is upregulated in metastatic breast cancer cells enabling de novo production of NADP(H) and the expansion of the NADP(H) pools thereby increasing the ability of these cells to adapt to the challenges of the metastatic cascade and efficiently metastasize. Mechanistically, we found that metastatic signals lead to a histone H3.3 variant-mediated epigenetic regulation of the NADK promoter, resulting in increased NADK levels in cells with metastatic ability. Together, our work presents a previously uncharacterized role for NADK and de novo NADP(H) production as a contributor to breast cancer progression and suggests that NADK constitutes an important and much needed therapeutic target for metastatic breast cancers
Acidic Methanol Treatment Facilitates Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Imaging of Energy Metabolism
Detection of small molecule metabolites (SMM), particularly
those
involved in energy metabolism using MALDI-mass spectrometry imaging
(MSI), is challenging due to factors including ion suppression from
other analytes present (e.g., proteins and lipids). One potential
solution to enhance SMM detection is to remove analytes that cause
ion suppression from tissue sections before matrix deposition through
solvent washes. Here, we systematically investigated solvent treatment
conditions to improve SMM signal and preserve metabolite localization.
Washing with acidic methanol significantly enhances the detection
of phosphate-containing metabolites involved in energy metabolism.
The improved detection is due to removing lipids and highly polar
metabolites that cause ion suppression and denaturing proteins that
release bound phosphate-containing metabolites. Stable isotope infusions
of [13C6]nicotinamide coupled to MALDI-MSI (âIso-imagingâ)
in the kidney reveal patterns that indicate blood vessels, medulla,
outer stripe, and cortex. We also observed different ATP:ADP raw signals
across mouse kidney regions, consistent with regional differences
in glucose metabolism favoring either gluconeogenesis or glycolysis.
In mouse muscle, Iso-imaging using [13C6]glucose
shows high glycolytic flux from infused circulating glucose in type
1 and 2a fibers (soleus) and relatively lower glycolytic flux in type
2b fiber type (gastrocnemius). Thus, improved detection of phosphate-containing
metabolites due to acidic methanol treatment combined with isotope
tracing provides an improved way to probe energy metabolism with spatial
resolution in vivo
Acidic Methanol Treatment Facilitates Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Imaging of Energy Metabolism
Detection of small molecule metabolites (SMM), particularly
those
involved in energy metabolism using MALDI-mass spectrometry imaging
(MSI), is challenging due to factors including ion suppression from
other analytes present (e.g., proteins and lipids). One potential
solution to enhance SMM detection is to remove analytes that cause
ion suppression from tissue sections before matrix deposition through
solvent washes. Here, we systematically investigated solvent treatment
conditions to improve SMM signal and preserve metabolite localization.
Washing with acidic methanol significantly enhances the detection
of phosphate-containing metabolites involved in energy metabolism.
The improved detection is due to removing lipids and highly polar
metabolites that cause ion suppression and denaturing proteins that
release bound phosphate-containing metabolites. Stable isotope infusions
of [13C6]nicotinamide coupled to MALDI-MSI (âIso-imagingâ)
in the kidney reveal patterns that indicate blood vessels, medulla,
outer stripe, and cortex. We also observed different ATP:ADP raw signals
across mouse kidney regions, consistent with regional differences
in glucose metabolism favoring either gluconeogenesis or glycolysis.
In mouse muscle, Iso-imaging using [13C6]glucose
shows high glycolytic flux from infused circulating glucose in type
1 and 2a fibers (soleus) and relatively lower glycolytic flux in type
2b fiber type (gastrocnemius). Thus, improved detection of phosphate-containing
metabolites due to acidic methanol treatment combined with isotope
tracing provides an improved way to probe energy metabolism with spatial
resolution in vivo
Acidic Methanol Treatment Facilitates Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Imaging of Energy Metabolism
Detection of small molecule metabolites (SMM), particularly
those
involved in energy metabolism using MALDI-mass spectrometry imaging
(MSI), is challenging due to factors including ion suppression from
other analytes present (e.g., proteins and lipids). One potential
solution to enhance SMM detection is to remove analytes that cause
ion suppression from tissue sections before matrix deposition through
solvent washes. Here, we systematically investigated solvent treatment
conditions to improve SMM signal and preserve metabolite localization.
Washing with acidic methanol significantly enhances the detection
of phosphate-containing metabolites involved in energy metabolism.
The improved detection is due to removing lipids and highly polar
metabolites that cause ion suppression and denaturing proteins that
release bound phosphate-containing metabolites. Stable isotope infusions
of [13C6]nicotinamide coupled to MALDI-MSI (âIso-imagingâ)
in the kidney reveal patterns that indicate blood vessels, medulla,
outer stripe, and cortex. We also observed different ATP:ADP raw signals
across mouse kidney regions, consistent with regional differences
in glucose metabolism favoring either gluconeogenesis or glycolysis.
In mouse muscle, Iso-imaging using [13C6]glucose
shows high glycolytic flux from infused circulating glucose in type
1 and 2a fibers (soleus) and relatively lower glycolytic flux in type
2b fiber type (gastrocnemius). Thus, improved detection of phosphate-containing
metabolites due to acidic methanol treatment combined with isotope
tracing provides an improved way to probe energy metabolism with spatial
resolution in vivo
Acidic Methanol Treatment Facilitates Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Imaging of Energy Metabolism
Detection of small molecule metabolites (SMM), particularly
those
involved in energy metabolism using MALDI-mass spectrometry imaging
(MSI), is challenging due to factors including ion suppression from
other analytes present (e.g., proteins and lipids). One potential
solution to enhance SMM detection is to remove analytes that cause
ion suppression from tissue sections before matrix deposition through
solvent washes. Here, we systematically investigated solvent treatment
conditions to improve SMM signal and preserve metabolite localization.
Washing with acidic methanol significantly enhances the detection
of phosphate-containing metabolites involved in energy metabolism.
The improved detection is due to removing lipids and highly polar
metabolites that cause ion suppression and denaturing proteins that
release bound phosphate-containing metabolites. Stable isotope infusions
of [13C6]nicotinamide coupled to MALDI-MSI (âIso-imagingâ)
in the kidney reveal patterns that indicate blood vessels, medulla,
outer stripe, and cortex. We also observed different ATP:ADP raw signals
across mouse kidney regions, consistent with regional differences
in glucose metabolism favoring either gluconeogenesis or glycolysis.
In mouse muscle, Iso-imaging using [13C6]glucose
shows high glycolytic flux from infused circulating glucose in type
1 and 2a fibers (soleus) and relatively lower glycolytic flux in type
2b fiber type (gastrocnemius). Thus, improved detection of phosphate-containing
metabolites due to acidic methanol treatment combined with isotope
tracing provides an improved way to probe energy metabolism with spatial
resolution in vivo